Please use this identifier to cite or link to this item: https://dspace.ncfu.ru/handle/20.500.12258/19500
Title: New Heterocyclisation Reactions of 5-Amino-3-(cyanomethyl)-1H-pyrazole-4-carbonitrile with Some 1,3-Dielectrophilic Agents
Authors: Dotsenko, V. V.
Доценко, В. В.
Aksenov, N. A.
Аксенов, Н. А.
Aksenova, I. V.
Аксенова, И. В.
Keywords: 3(5)-aminopyrazoles;Calculated biological activity;Dicyandiamide;Pyrazolo[1,5-a]pyrimidines;Quantum chemical studies
Issue Date: 2022
Publisher: Pleiades journals
Citation: Semenova, A. M., Gadzhiakhmedova, Y. R., Bespalov, A. V., Dotsenko, V. V., Aksenov, N. A., Aksenova, I. V. New Heterocyclisation Reactions of 5-Amino-3-(cyanomethyl)-1H-pyrazole-4-carbonitrile with Some 1,3-Dielectrophilic Agents // Russian Journal of General Chemistry. - 2022. - Том 92. - Выпуск 3. - Стр.: 367 - 382. - DOI10.1134/S1070363222030057
Series/Report no.: Russian Journal of General Chemistry
Abstract: 5-Amino-3-(cyanomethyl)-1H-pyrazole-4-carbonitrile enters into condensation reactions with β-diketones and dibenzalacetone to form 2-(cyanomethyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives. The reaction with cyanoguanidine in an acid medium leads to the formation of 2,4-diamino-7-(cyanomethyl)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile. Structure of the obtained compounds was confirmed by spectral data, as well as the results of a quantum chemical study of possible reaction routes for the reaction of 5-amino-3-(cyanomethyl)-1H-pyrazole-4-carbonitrile with benzoyltrifluoroacetone. Bioavailability parameters were predicted for the obtained products in silico, and possible protein targets were predicted by protein-ligand docking.
URI: http://hdl.handle.net/20.500.12258/19500
Appears in Collections:Статьи, проиндексированные в SCOPUS, WOS

Files in This Item:
File Description SizeFormat 
WoS 1411 .pdf
  Restricted Access
119.75 kBAdobe PDFView/Open
scopusresults 2151 .pdf
  Restricted Access
132.57 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.